A model for conducting clinical-outcome research: An adaptation of the standard protocol for use in aphasiology

Aphasiology

Volumn 12, Issue 9, 1998, Pages 787-810

  Robey, Randall R ^a   Schultz, Martin C ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APHASIA; COMMUNICATION DISORDER; METHODOLOGY; MODEL; OUTCOMES RESEARCH; REIMBURSEMENT; REVIEW; STANDARD;

EID: 0031694037     PISSN: 02687038     EISSN: None     Source Type: Journal    
DOI: 10.1080/02687039808249573     Document Type: Review

References (118)

1. AMERICAN ACADEMY OF NEUROLOGY, 1994, Definitions and quality of evidence ratings. Neurology, 44, 567.
2. ATTANASIO, J. S. 1994, Inferential statistics and treatment efficacy studies in communication disorders. Journal of Speech and Hearing Research, 37, 755-759.
3. BARCIKOWSKI, R. S. and ROBEY, R. R. 1984, Decisions in the single group repeated measures analysis: statistical tests and three computer packages. American Statistician, 38, 148-150.
4. BASSO, A. 1992, Prognostic factors in aphasia. Aphasiology, 6, 337-348.
5. BENJAMIN, K. 1995, Outcomes research and the allied health professional. Journal of Allied Health, 24, 3-12.
6. BOYSEN, A. E. and WERTZ, R. T. 1996, Clinical costs in aphasia treatment: how much is a word worth? In M. L. Lemme (Ed.) Clinical Aphasiology, vol. 24 (Austin, TX: Pro-Ed), pp. 207-213.
7. BROOK, R. H. and LOHR, K. N. 1985, Efficacy, effectiveness, variations, and quality: boundary crossing research. Medical Care, 23, 710-722.
8. BROUWERS, P. and MOHR, E. 1991, Design of clinical trials. In E. Mohr and P. Brouwers (Eds) Handbook of Clinical Trials: The neurobehavioural approach (Amsterdam: Swets & Zeitlinger), pp. 45-66.
9. BROWNE, T. R. 1993, Clinical trials performed for the new drug approval process in the United States: standard methods and alternative methods. Epilepsy Research, 10 (Suppl. 10), 31-44.
10. BUNKER, J. P. 1988, Is efficacy the gold standard for quality assessment? Inquiry, 25, 51-58.
11. CARTER, S. K. 1984, Clinical aspects in the design and conduct of phase II trials. In M. E. Buyse, M. J. Staquet and R. J. Sylvester (Eds) Cancer Clinical Trials: Methods and practice (New York: Oxford University Press), pp. 223-238.
12. CHALMERS, T. C. 1981, The clinical trial. Milbank Memorial Fund Quarterly/Health and Society, 59, 324-339.
13. CLEOPHAS, T. J. M. and TAVENIER, P. 1995, Clinical trials in chronic diseases. Journal of Clinical Pharmacology, 35, 594-598.
14. COHEN, J. 1988, Statistical Power Analysis for the Behavioural Sciences, 2nd edn (Hillsdale, NJ: Lawrence Erlbaum).
15. COOK, T. D. and CAMPBELL, D. T. 1979, Quasi-experimentation: Design and analysis issues for field settings (Boston, MA: Houghton Mifflin).
16. COX, J. D. 1994, Brief history of comparative clinical trials in radiation oncology: perspectives from the silver anniversary of the radiation oncology group. Radiology, 192, 25-32.
17. CRERAR, M. A. 1991, A computer-based microworld for the assessment and remediation of sentence processing deficits in aphasia. Doctoral dissertation, Napier Polytechnic in collaboration with Queen Margaret College, Edinburgh, Scotland.
18. CULLEN, J. W. 1986, A rationale for health promotion in cancer control. Preventative Medicine, 15, 442-450.
19. CULLEN, J. W. 1988, The National Cancer Institute's intervention trials. Cancer, 62, 1851-1864.
20. DA PRATO, R. A. 1992, Large-group fantasies versus single-subject science. Topics in Early Childhood Special Education, 12, 54-65.
21. DARLEY, F. L. 1972, The efficacy of language rehabilitation in aphasia. Journal of Speech and Hearing Disorders, 37, 3-21.
22. DARLEY, F. L. 1982, Aphasia. Philadelphia, PA: W. B. Saunders.
23. DAVID, R., ENDERBY, P. and BAINTON, D. 1982, Treatment of acquired aphasia: speech therapists and volunteers compared. Journal of Neurology, Neurosurgery, and Psychiatry, 4, 957-961.
24. DE KLEIJN-DE VRANKRIJKER, M. W. 1995, The international classification of impairments, disabilities, and handicaps (ICIDH): perspectives and development (Part I). Disability and Rehabilitation, 17, 109-111.
25. DUBEY, S. D. 1986, Current thoughts on crossover designs. Clinical Research and Practice in Drug Regulatory Affairs, 127-142.
26. DUFFY, J. R. 1994, Schuell's stimulation approach to rehabilitation. In R. Chapey (Ed.) Language Intervention Strategies in Adult Aphasia, 3rd edn (Baltimore, MA: Williams & Wilkins), pp. 146-174.
27. EICK, T. J. and KOFOED, L. 1994, An unusual indication for a single-subject clinical trial. Journal of Nervous and Mental Disease, 182, 587-590.
28. ELDER, J. H. 1995, In-home communication intervention training for parents of multiply handicapped children. Scholarly Inquiry for Nursing Practice, 9, 71-92.
29. FELD, R. 1993, Organization of clinical trials: problems, controversies, definitions, and methodology related to infections in neurogenic patients. Recent Results in Cancer Research, 132, 249-256.
30. FITZ-GIBBON, C. T. 1986, In defense of randomised controlled trials, with suggestions about possible use of meta-analysis. British Journal of Disorders of Communication, 21, 117-124.
31. FLAY, B. R. 1986, Efficacy and effectiveness trials (and other phases of research in the development of health promotion programs). Preventative Medicine, 15, 451-474.
32. FLEISS, J. L. 1986, The Design and Analysis of Clinical Experiments (New York: John Wiley & Sons).
33. FLEISS, J. L. 1989, A critique of recent research on the two-treatment crossover design. Controlled Clinical Trials, 10, 237-243.
34. FLIEGER, K. 1989, How experimental drugs are tested in humans. Pediatric Infectious Diseases Journal, 8, 160-162.
35. FOOD AND DRUG ADMINISTRATION, 1977, General Considerations for the Clinical Evaluation of Drugs. HEW(FDA)77-3040 (Washington, DC: US Government Printing Office).
36. FRIEDMAN, L. M., FURBERG, C. D. and DEMETS, D. L. 1996, Fundamentals of Clinical Trials, 3rd edn (St Louis, MO: Mosby).
37. GEHAN, E. A. 1961, The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. Journal of Chronic Diseases, 13, 246-353.
38. GEHAN, E. A. 1979, Clinical trials in cancer research. Environmental Health Perspectives, 32, 31-48.
39. GEHAN, E. A. and SCHNEIDERMAN, M. A. 1990, Historical and methodological developments in clinical trials at the National Cancer Institute. Statistics in Medicine, 9, 871-880.
40. GRACON, S. I., GAMZU, E. R. and MANCINI, A. D. J. 1991, Multicenter clinical trials: Design considerations, standardization and implementation. In E. Mohr and P. Brouwers (Eds) Handbook of Clinical Trials: The neurobebavioural approach (Amsterdam: Swets & Zeitlinger), pp. 275-291.
41. GREENWALD, P. and CULLEN, J. W. 1984, The scientific approach to cancer control. Ca - A Journal for Clinicians, 34, 328-332.
42. GREENWALD, P. and CULLEN, J. W. 1985, The new emphasis in cancer control. Journal of the National Cancer Institute, 74, 543-551.
43. GRIEVE, A. P. 1990, Crossover versus parallel designs. In D. A. Berry (Ed.) Statistical Methodology in the Pharmaceutical Sciences (New York: Marcel Dekker), pp. 239-270.
44. GRIZZLE, J. E. 1965, The two-period change-over design and its use in clinical trials. Biometrics, 21, 467-480.
45. GRIZZLE, J. E. 1974, Corrections to 'The two-period change-over design and its use in clinical trials.' Biometrics, 30, 727.
46. GUYATT, G., SACKETT, D., TAYLOR, W., CHONG, J., ROBERTS, R. and PUGSLEY, S. 1986, Determining optimal therapy - randomized trials in individual patients. New England Journal of Medicine, 314, 889-892.
47. HARMS, S. E., RADENSKY, P., SUNSHINE, J., DAVIS, D. O., OKUNIEFF, P., FARR, C. and SPETTELL, C. 1996, MRI efficacy and effectiveness research: who needs it and who pays for it? Journal of Magnetic Resonance Imaging, 6, 4-6.
48. HELM-ESTABROOKS, N. and RAMSBERGER, G. 1986, Treatment of agrammatism in long-term Broca's aphasia. British Journal of Disorders of Communication, 21, 39-45.
49. HILLS, M. and ARMITAGE, P. 1979, The two-period cross-over clinical trial. British Journal of Clinical Pharmacology, 8, 7-20.
50. HOAGWOOD, K. HIBBS, E. BRENT, D. and JENSEN, P. 1995, Introduction to the special section: efficacy and effectiveness in studies of child and adolescent psychotherapy. Journal of Consulting and Clinical Psychology, 63, 683-687.
51. HODGSON, M. 1993, N-of-one clinical trials: the practice of environmental and occupational medicine. Journal of Occupational Medicine, 35, 375-380.
52. HOLLAND, A. L. and WERTZ, R. T. 1988, Measuring aphasia treatment effects: large-group, small-group, and single-subject studies. In F. Plum (Ed.) Language, Communication, and the Brain (New York: Raven Press), pp. 267-273.
53. HOLLAND, A. L., FROMM, D. S., DERUYTER, F. and STEIN, M. 1996, Treatment efficacy: aphasia. Journal of Speech and Hearing Research, 39, S27-S36.
54. HOWARD, D. 1986, Beyond randomised controlled trials: the case for effective case studies of the effects of treatment in aphasia. British Journal of Disorders of Communication, 21, 89-102.
55. HOWARD, K. I., MORAS, K. BRILL, P. L., MARTINOVICH, Z. and LUTZ, W. 1996, Evaluation of psychotherapy: efficacy, effectiveness, and patient progress. American Psychologist, 51, 1059-1064.
56. JACOBSON, N. S. and CHRISTENSEN, A. 1996, Studying the effectiveness of psychotherapy: how well can clinical trials do the job? American Psychologist, 51, 1031-1039.
57. JENKINS, J. and HUBBARD, S. 1991, History of clinical trials. Seminars in Oncology Nursing, 7, 228-234.
58. JOHNSON, J. R. and TEMPLE, R. 1985, Food and Drug Administration requirements for the approval of new anticancer drugs. Cancer Treatment Reports, 69, 1155-1157.
59. JOHNSTON, M. V. and GRANGER, C. V. 1994, Outcomes research in medical rehabilitation: a primer and introduction to a series. American Journal of Physical Medicine and Rehabilitation, 73, 296-303.
60. JOHNSTON, M. V., OTTENBACHER, K. J. and REICHARDT, C. S. 1995, Strong quasi-experimental designs for research on the effectiveness of rehabilitation. American Journal of Physical Medicine and Rehabilitation, 74, 383-392.
61. JONES, B. and KENWARD, M. G. 1989, Design and Analysis of Cross-over Trials (New York: Chapman & Hall).
62. KAZDIN, A. E., KRATOCHWILL, T. R. and VANDENBOS, G. R. 1986, Beyond clinical trials: generalizing from research to practice. Professional Psychology - Research and Practice, 17, 391-398.
63. KILTIE, H. 1979, Planning a coordinated set of clinical trials. In J. Levine (Ed.) Coordinating Clinical Trials in Psychopharmacology: Planning, documentation, and analysis (National Institute of Mental Health Publication No. HEW 79-803) (Washington, DC: US Government Printing Office).
64. KUNKEL, R. S. 1987, Clinical trials in migraine: parallel versus crossover studies. Neuroepidemiology, 6, 209-213.
65. LEVENTHAL, B. G. 1988, An overview of clinical trials in oncology. Seminars in Oncology, 15, 414-422.
66. LINCOLN, N. B., PICKERSGILL, M. J., HANKEY, A. I. and HILTON, C. R. 1982, An evaluation of operant training and speech therapy in the language rehabilitation of moderate aphasics. Behavioural Psychotherapy, 10, 162-178.
67. LINDEN, M. 1984, Phase-IV research: specifics, objectives and methodology. Pharmacopsychiatry, 17, 140-142.
68. LOHR, K. N. 1988, Outcome measurement: concepts and questions. Inquiry, 25, 37-50.
69. LOUIS, T. A., LAVORI, P. I.; BAILAR, J. C. and POLANSKY, M. 1992, Crossover and self-controlled designs in clinical research. In J. C. Bailar and F. Mosteller (Eds) Medical Uses of Statistics, 2nd edn (Boston, MA: NEJM Books), pp. 83-103.
70. MAPLESON, W. W. 1989, Organising clinical research: 3. Trial design. British Journal of Clinical Practice, 43, 89-93.
71. MAXWELL, S. E. and DELANEY, H. D. 1990, Designing Experiments and Analyzing Data: A model comparison perspective (Belmont, CA: Wadsworth).
72. MEIKLE, M., WECHSLER, E. TUPPER, A. BENENSON, M., BUTLER, J., MULHALL, D. and STERN, G. 1979, Comparative trial of volunteers and professional treatments of dysphasia after stroke. British Medical Journal, 2, 87-89.
73. MEINERT, C. L. 1996, Clinical trials: the gold standard for evaluation of therapy. Ophthalmology, 103, 869-870.
74. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE, 1987, Guidelines for Demonstration and Education Research Grants (Washington, DC: US Government Printing Office).
75. NIH recommends funding ASHA's clinical trials grant application, (November 1996) ASHA Leader, 1(24), 1.
76. OFFICE OF TECHNOLOGY ASSESSMENT, 1978, Assessing the Efficacy and Safety of Medical Technologies. OTA-H-75 (Washington, DC: US Government Printing Office).
77. OFFICE OF TECHNOLOGY ASSESSMENT, 1980, The Implication of Cost-effectiveness Analysis of Medical Technology. OTA-H-126 (Washington, DC: US Government Printing Office).
78. OFFICE OF TECHNOLOGY ASSESSMENT, 1982, Postmarketing Surveillance of Prescription Drugs. OTA-H-189 (Washington, DC: US Government Printing Office).
79. OLSWANG, L. B. 1990, Treatment efficacy: the breadth of research. In L. B. Olswang, C. K. Thompson, S. F. Warren and N. J. Minghetti (Eds) Treatment Efficacy Research in Communication Disorders (Rockville, MD: American Speech-Language-Hearing Association), pp. 99-103.
80. O'NEILL, R. 1977, A report on the two-period cross-over design and its applicability in trials of clinical effectiveness. Report of the Food and Drug Administration's Biometric and Epidemiological Methodology Advisory Committee (Washington, DC: US Government Printing Office).
81. PARLOFF, M. B. 1986, Placebo controls in psychotherapy research: a sine qua non or a placebo for research problems? Journal of Consulting and Clinical Psychology, 54, 79-87.
82. PIANTADOSI, S. 1988, Principles of clinical trial design. Seminars in Oncology, 15, 423-433.
83. POCOCK, S. J. 1983, Clinical Trials: A practical approach (New York: John Wiley & Sons).
84. PRING, T. R. 1986, Evaluating the effects of speech therapy for aphasics: developing the single case methodology. British Journal of Disorders of Communication, 21, 103-115.
85. PRING, T. R. 1987, On choosing a methodology to assess effectiveness of therapeutic interventions: a brief reply to FitzGibbon. British Journal of Disorders of Communication, 22, 163-166.
86. RATKOWSKY, D. A., EVANS, M. A. and ALLDREDGE, J. R. (eds), 1993, Cross-over Experiments: Design, analysis, and application (New York: Marcel Dekker).
87. ROBEY, R. R. 1994, The efficacy of treatment for aphasic persons : a meta-analysis. Brain and Language, 47, 585-608.
88. ROBEY, R. R. 1998, A meta-analysis of clinical outcomes in the treatment of aphasia. Journal of Speech, Language, and Hearing Research (In press).
89. ROBEY, R. R. and SCHULTZ, M. C. 1993, Optimizing Theories and Experiments (San Diego, CA: Singular Publishing Group).
90. ROXBOROUGH, L. 1995, Review of the efficacy and effectiveness of adaptive seating for children with cerebral palsy. Assistive Technology, 7, 17-25.
91. RUFF, R. M. and CROUCH, J. A. 1991, Design of clinical trials. In E. Mohr and P. Brouwers (Eds) Handbook of Clinical Trials: The neurobehavioural approach (Amsterdam: Swets & Zeitlinger), pp. 89-119.
92. SARNO, M. T. 1991, Recovery and rehabilitation in aphasia. In M. T. Sarno (Ed.) Acquired Aphasia, 2nd edn (San Diego, CA: Academic Press), pp. 521-582.
93. SARNO, M. T. 1997, Quality of life in aphasia in the first post-stroke year. Aphasiology, 11, 665-679.
94. SCHOENBAUM, S. C. 1980, Cost/effectiveness considerations in clinical trials. Triangle, 19, 103-106.
95. SEDERER, L. I. DICKEY, B. and HERMANN, R. C. 1996, The imperative of outcomes assessment in psychiatry. In L. I. Sederer and B. Dickey (Eds) Outcomes Assessment in Clinical Practice (Baltimore, MD: Williams & Wilkins), pp. 1-7.
96. SENN, S. J. 1988, Cross-over trials, carry-over effects and the art of self-delusion. Statistics in Medicine, 7, 1099-1101.
97. SENN, S. 1992, is the 'simple carry-over' model useful? Statistics in Medicine, 11, 715-26.
98. SENN, S. 1993a, Cross-over Trials in Clinical Research (New York: John Wiley & Sons).
99. SENN, S. 1993b, Suspended judgment: N-of-1 trials. Controlled Clinical Trials, 14, 1-5.
100. SHADISH, W. R., RAGSDALE, K., GLASER, R. R. and MONTGOMERY, L. M. 1995, The efficacy and effectiveness of marital and family therapy: a perspective from meta-analysis. Journal of Marital and Family Therapy, 21, 345-360.
101. SHAPIRO, D. A. 1989, Outcome research. In G. Parry and F. N. Watts (Eds) Behavioural and Mental Health Research: A Handbook of Skills and Methods (London: Lawrence Erlbaum), pp. 163-187.
102. SHEWAN, C. M. 1986, The history and efficacy of aphasia treatment. In R. Chapey (Ed.) Language Intervention Strategies in Adult Aphasia, 2nd edn (Baltimore, MD: Williams & Wilkins), pp. 28-43.
103. SHEWAN, C. M. 1989, Quality is not a four letter word. ASHA, 31, 51-55.
104. SIEGEL, G. M. and YOUNG, M. A. 1987, Group designs in clinical research. Journal of Speech and Hearing Disorders, 52, 194-199.
105. SIMON, R. 1989, Designs for efficient clinical trials. Oncology, 3, 43-53.
106. SPILKER, B. 1984, Guide to Clinical Studies and Developing Protocols (New York: Raven Press).
107. SPILKER, R. 1991, Guide to Clinical Trials (New York: Raven Press).
108. SPILKER, B. 1996, Introduction. In B. Spilker (Ed.) Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd edn (Philadelphia, PA: Lippincott-Raven), pp. 1-10.
109. SPRIET, A., DUPIN-SPRIET, T. and SIMON, P. 1994, Methodology of Clinical Drug Trials, 2nd edn (Basel: Karger).
110. SPRINGER, L., WILLMES, K. and KAAG, E. 1993, Training in the use of wh-questions and prepositions in dialogues: a comparison of two different approaches in aphasia therapy. Aphasiology, 7, 251-270.
111. SYLVESTER, R. 1984, Planning cancer clinical trials. In M. E. Buyse, M. J. Staquet and R. J. Sylvester (Eds) Cancer Clinical Trials: Methods and practice (Oxford: Oxford University Press), pp. 47-63.
112. VITALIANO, P. P., PRINZ, P., VITIELLO, M. V., OLSHAN, A. and ROEHRS, T. A. 1981, On the use of repeated measures designs in psychopharmacology. Psychopharmacology, 72, 247-249.
113. WELLS, K. B. and STURM, R. 1996, Informing the policy process: from efficacy to effectiveness data on pharmacotherapy. Journal of Consulting and Clinical Psychology, 64, 638-645.
114. WERTZ, R. T., WEISS, D. G., ATEN, J. L., BROOKSHIRE, R. H., GARCIA-BUÑUEL, L., HOLLAND, A. L., KURTZKE, J. F., LAPOINTE, L. L., MILIANTI, F. J., BRANNEGAN, R., GREENBAUM, H., MARSHALL, R. C., VOGEL, D., CARTER, J., BARNES, N. S. and GOODMAN, R. 1986, Comparison of clinic, home, and deferred language treatment for aphasia: a Veterans Affairs cooperative study. Archives of Neurology, 43, 653-658.
115. WHISNANT, J. P. 1996, Effectiveness versus efficacy of treatment of hypertension for stroke prevention. Neurology, 46, 301-307.
116. WILCOX, R. R. 1987, New Statistical Procedures for the Social Sciences: Modern solutions to basic problems (Hillsdale, NJ: Lawrence Erlbaum Associates).
117. WOODS, J. R., WILLIAMS, J. G. and TAVEL, M. 1989, The two-period crossover design in medical research. Annals of Internal Medicine, 110, 560-566.
118. WORLD HEALTH ORGANIZATION, 1975, WHO Scientific Group on Guidelines for Evaluation of Drugs for Use in Man (Geneva: World Health Organization).